Degree in Artificial intelligence- AI
Aartificial intelligence, Agile methodologies, Analytical and Problem solving, Automation, Azure, Big Data Technology, Design, DevOps, Effective communication skills, Figma, GitLab, IT, Leadership Skill, Machine learning techniques, PowerBI, PowerShell Programming, SharePoint, SLA
We are looking for an innovation-centric Senior Software Engineer, Intelligent Automation, R&D Digital Products to join our IT R&D (Research & Development) Team who is passionate about designing, developing, and implementing automation solutions using platforms such as Microsoft Power Platform amongst others. The Senior Software Engineer will work with a team of developers and architects to create innovative solutions that improve efficiency and productivity, supporting R&D business requirements. The Senior Software Engineer will execute Intelligent Automations for Research, Discovery, and Development activities to enable data-driven insights to the R&D business. This position will report to the Intelligent Automation Architect, R&D Digital Products in IT.
Your Responsibility:
Your Qualifications:
Why Genmab? Be part of a multicultural, innovative environment where your work directly impacts cancer patients' lives. Our unique culture fosters experimentation, empowerment, and growth. We value teamwork, diversity, and an inclusive, supportive work environment. At Genmab, diversity drives our success. We ensure a professional, inclusive environment, valuing different perspectives and experiences. Ready to make a real difference in transforming patient care? Apply now to be part of Genmab's journey in advancing innovative healthcare solutions!
About You
Locations
Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.
About Genmab
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
Our commitment to diversity, equity, and inclusion
We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website https://www.genmab.com/privacy.
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schonharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark - internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan.
Princeton, NJ, USA
2-4 year
Utrecht, Netherlands
2-4 year
Utrecht, Netherlands
6-8 year
Copenhagen, Denmark
6-8 year
Princeton, NJ, USA
6-8 year
Princeton, NJ, USA
6-8 year
Copenhagen, Denmark
6-8 year
Utrecht, Netherlands
6-8 year
Utrecht, Netherlands
6-8 year
Princeton, NJ, USA
6-8 year
Utrecht, Netherlands
6-8 year
Copenhagen, Denmark
6-8 year
Copenhagen, Denmark
6-8 year
Utrecht, Netherlands
6-8 year